{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:55:57Z","timestamp":1782496557151,"version":"3.54.5"},"reference-count":26,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004695","name":"University of KwaZulu-Natal","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004695","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,29]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Therapy-associated thrombosis remains a challenge in the management of patients with acute lymphoblastic leukaemia (ALL). Thrombosis associated with asparaginase-containing chemotherapy complicates patient management strategies, prompting the need for effective prophylaxis. Assessing the relationship between chemotherapy-induced thrombosis and patient outcomes is crucial for optimising ALL management strategies. The aim of this systematic review is to provide a synthesis on whether the development of thrombosis during asparaginase-containing chemotherapy regimens impacts the overall and event-free survival of patients with ALL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Data sources<\/jats:italic>\n                      : to identify relevant studies, a comprehensive search will be conducted on the major electronic databases, including MEDLINE (PubMed), Web of Science (Clarivate), Academic Search Complete (EBSCOhost), clinicaltrial.gov and the Cochrane Central Register of Controlled Trials from inception to 30 January 2026.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic>Inclusion criteria for selecting studies<\/jats:italic>\n                      : randomised and non-randomised clinical studies evaluating the impact of asparaginase-containing chemotherapy-associated thrombosis on survival outcomes in patients with ALL will be included. Two reviewers will independently screen the retrieved studies, extract data and assess study quality using a predefined criteria. A narrative synthesis will be undertaken, and if feasible, meta-analyses will be conducted. A subgroup and sensitivity analysis will be performed to explain the sources of heterogeneity. The quality of cumulative evidence will be assessed using the grading of recommendations assessment, development and evaluation tool. The findings from this systematic review will inform evidence-based clinical guidelines for thrombosis risk assessment and management in patients with ALL, potentially improving treatment outcomes and reducing thrombosis-related morbidity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>No ethical approval will be required and the findings of this meta-analysis will be published in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:named-content content-type=\"\">Trial registration number<\/jats:named-content>\n                    <\/jats:title>\n                    <jats:p>CRD42024532665.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-106123","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:55:35Z","timestamp":1771253735000},"page":"e106123","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of treatment-induced thrombosis on the prognosis of acute lymphoblastic leukaemia: a protocol for a systematic review and meta-analysis"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-3734","authenticated-orcid":false,"given":"Zekhethelo A","family":"Mkhwanazi","sequence":"first","affiliation":[{"name":"School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyesanmi A","family":"Fabunmi","sequence":"additional","affiliation":[{"name":"Section Sports Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, Gauteng, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-1992","authenticated-orcid":false,"given":"Bongani B","family":"Nkambule","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2026062610412813000_16.2.e106123.1","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00905-2","article-title":"Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions","volume":"13","author":"Samra","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2026062610412813000_16.2.e106123.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08524.x"},{"key":"2026062610412813000_16.2.e106123.3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ajh.26193","article-title":"Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C","volume":"96","author":"Pelland-Marcotte","year":"2021","journal-title":"Am J Hematol"},{"key":"2026062610412813000_16.2.e106123.4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ajh.27171","article-title":"Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP-C","volume":"99","author":"Pelland-Marcotte","year":"2024","journal-title":"Am J Hematol"},{"key":"2026062610412813000_16.2.e106123.5","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-018-3394-6","article-title":"Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study","volume":"97","author":"Forbrigger","year":"2018","journal-title":"Ann Hematol"},{"key":"2026062610412813000_16.2.e106123.6","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26938","article-title":"Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation","volume":"65","author":"Athale","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2026062610412813000_16.2.e106123.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015511"},{"key":"2026062610412813000_16.2.e106123.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02383.x"},{"key":"2026062610412813000_16.2.e106123.9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.041","article-title":"Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia","volume":"24","author":"Zuurbier","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026062610412813000_16.2.e106123.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-175745"},{"key":"2026062610412813000_16.2.e106123.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-263012"},{"key":"2026062610412813000_16.2.e106123.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.10.007"},{"key":"2026062610412813000_16.2.e106123.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(01)00286-9"},{"key":"2026062610412813000_16.2.e106123.14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12948"},{"key":"2026062610412813000_16.2.e106123.15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12098-013-1158-9","article-title":"Management of thrombotic complications in acute lymphoblastic leukemia","volume":"80","author":"Zia","year":"2013","journal-title":"Indian J Pediatr"},{"key":"2026062610412813000_16.2.e106123.16","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.828702","article-title":"Thrombosis Complications in Pediatric Acute Lymphoblastic Leukemia: Risk Factors, Management, and Prevention: Is There Any Role for Pharmacologic Prophylaxis?","volume":"10","author":"Rodriguez","year":"2022","journal-title":"Front Pediatr"},{"key":"2026062610412813000_16.2.e106123.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116327"},{"key":"2026062610412813000_16.2.e106123.18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/rth2.12182","article-title":"Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis","volume":"3","author":"Klaassen","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"2026062610412813000_16.2.e106123.19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s11684-022-0958-6","article-title":"Venous thromboembolism in children with acute lymphoblastic leukemia in China: a report from the Chinese Children\u2019s Cancer Group-ALL-2015","volume":"17","author":"Yin","year":"2023","journal-title":"Front Med"},{"key":"2026062610412813000_16.2.e106123.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1211"},{"key":"2026062610412813000_16.2.e106123.21","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13162"},{"key":"2026062610412813000_16.2.e106123.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2026062610412813000_16.2.e106123.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2026062610412813000_16.2.e106123.24","doi-asserted-by":"crossref","DOI":"10.2307\/3001666","article-title":"The Combination of Estimates from Different Experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"2026062610412813000_16.2.e106123.25","doi-asserted-by":"crossref","unstructured":"Schroll JB , Moustgaard R , G\u00f8tzsche PC . Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study. BMC Med Res Methodol 2011.","DOI":"10.1186\/1471-2288-11-22"},{"key":"2026062610412813000_16.2.e106123.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-106123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:43:54Z","timestamp":1782495834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-106123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,16]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-106123"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-106123","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}